CNS neuroscience & therapeutics

How the p62/Nrf2/Keap1 Pathway May Be Involved in Brain Problems Caused by Lead Exposure

Updated

Abstract

Lead (Pb) exposure may trigger excessive production of reactive oxygen species (ROS) and disrupt neuronal function.

  • Pb exposure is associated with increased levels of in neurons.
  • The protein P62 interacts with the Nrf2/Keap1 pathway, disrupting normal autophagy processes.
  • This disruption leads to the accumulation of Tau protein, which is linked to Alzheimer's disease.
  • Treatment with antioxidants and autophagy activators may reduce the harmful effects of Pb exposure on neurons.

Simplified

Key numbers

2 mg/kg
Increase in Levels
(CHO) administered to rats via intraperitoneal injections.
50 μM
Decrease in Expression
Concentration of leading to observable cellular damage in .

Key figures

FIGURE 1
Control vs -exposed rats: lead levels, learning and memory, and hippocampal tissue changes
Highlights higher lead accumulation and impaired memory with visible hippocampal damage in Pb-exposed rats
CNS-31-e70566-g003
  • Panel A
    Blood and Pb levels; Pb group shows significantly higher Pb concentrations than control
  • Panel B
    test results; Pb group has longer escape latency on days 4 and 5 and fewer probe times than control
  • Panel C
    of hippocampus and regions; Pb group shows visible cellular damage and structural changes indicated by arrows
  • Panel D
    of hippocampus CA3 and DG regions; Pb group appears to have reduced neuronal density compared to control
FIGURE 2
exposure vs oxidative damage and cell changes in
Highlights increased and reduced antioxidant activity in Pb-exposed neuronal cells.
CNS-31-e70566-g009
  • Panel A
    Cell viability decreases as Pb concentration increases from 0 to 200 μmol/L, with significant reductions at 25 μmol/L and above.
  • Panel B
    Phenotypic changes in SH-SY5Y cells stained for (red) and nuclei (blue) show altered cell morphology at increasing Pb concentrations (25, 50, 100 μmol/L) compared to control.
  • Panel C
    levels detected by (green) visibly increase with higher Pb concentrations, with the highest intensity at 200 μmol/L and in the positive control (Rosup).
  • Panel D
    activity measured in SH-SY5Y cells decreases with Pb exposure, with a statistically significant reduction at 100 μmol/L compared to control.
FIGURE 3
, , and protein expression in -exposed cells and rat
Highlights reduced antioxidant protein levels and increased Keap1 in Pb-exposed cells and rat brain tissue
CNS-31-e70566-g006
  • Panel A
    images of Nrf2 (green) and nuclei (, blue) in exposed to 0, 25, 50, and 100 µM Pb; Nrf2 signal visibly decreases with higher Pb concentrations
  • Panel B
    Western blots and quantification of Nrf2, Keap1, and HO-1 proteins in SH-SY5Y cells treated with 0, 25, 50, and 100 µM Pb; Nrf2 and HO-1 protein levels decrease while Keap1 protein levels increase with higher Pb doses
  • Panel C
    Western blots and quantification of Nrf2, Keap1, and HO-1 proteins in hippocampus tissue from control and Pb-exposed rats; Pb exposure reduces Nrf2 and HO-1 levels and increases Keap1 levels
FIGURE 4
-exposed cells and rats: protein levels related to and in neurons
Highlights increased and protein levels in Pb-exposed neurons and rat .
CNS-31-e70566-g005
  • Panel A
    Western blot of and P62 protein levels in exposed to 0, 25, 50, and 100 μM Pb with quantification; no significant changes in LC3II/I ratio, P62 appears slightly increased at 100 μM Pb.
  • Panel B
    images showing LC3 protein (red) and nuclei (blue) in SH-SY5Y cells under control, Pb exposure (25, 50, 100 μM), and Rapamycin (RAPA) treatment; LC3 signal appears visibly brighter in RAPA-treated cells.
  • Panel C
    Western blot of phosphorylated Tau (P-Tau) and total Tau in SH-SY5Y cells exposed to Pb with quantification; P-Tau levels increase significantly at 100 μM Pb.
  • Panel D
    Western blot of LC3 and P62 proteins in hippocampus of control and Pb-exposed rats with quantification; P62 protein level is significantly higher in Pb-exposed rats.
  • Panel E
    Western blot of phosphorylated Tau (P-Tau) and total Tau in hippocampus of control and Pb-exposed rats with quantification; P-Tau level is significantly higher in Pb-exposed rats.
FIGURE 5
, , and protein levels and overlap in of control vs -exposed rats
Highlights altered Nrf2, P62, and Keap1 protein patterns in Pb-exposed hippocampus versus controls
CNS-31-e70566-g001
  • Panels leftmost
    Low-magnification views of hippocampus sections stained with (blue) showing overall tissue structure in control and Pb-exposed rats
  • Panels second from left
    Higher magnification of DAPI-stained nuclei in control and Pb-exposed hippocampus
  • Panels middle
    P62 protein (red) expression in hippocampus of control and Pb-exposed rats
  • Panels second from right
    Nrf2 protein (green) expression in hippocampus of control and Pb-exposed rats
  • Panels rightmost
    Keap1 protein (purple) expression and merged image showing co-localization of DAPI, Nrf2, P62, and Keap1 in control and Pb-exposed hippocampus
1 / 5

Full Text

What this is

  • Lead (Pb) exposure contributes to neurodegenerative diseases by inducing and disrupting cellular pathways.
  • This study investigates the P62/Nrf2/Keap1 signaling pathway's role in Pb-induced neuronal dysfunction.
  • Findings indicate that Pb exposure leads to oxidative damage and impaired , highlighting potential therapeutic targets.

Essence

  • Pb exposure disrupts the P62/Nrf2/Keap1 signaling pathway, leading to and neurodegeneration. Treatments like antioxidants and Nrf2 activators may mitigate these effects.

Key takeaways

  • Pb exposure triggers excessive reactive oxygen species (ROS) production, leading to neuronal oxidative damage. This is characterized by increased Keap1 expression and decreased Nrf2 levels.
  • The protein P62 accumulates due to Pb exposure, disrupting normal autophagic processes and leading to Tau protein accumulation, which is associated with Alzheimer's disease.
  • Antioxidants like N-acetylcysteine and Nrf2 activators can ameliorate Pb-induced oxidative damage, suggesting potential therapeutic strategies for Pb neurotoxicity.

Caveats

  • The study primarily uses animal models, which may not fully replicate human responses to Pb exposure. Further research is needed to validate findings in human populations.
  • While treatments showed promise in mitigating Pb-induced damage, their efficacy in clinical settings remains to be established through rigorous trials.

Definitions

  • oxidative stress: An imbalance between the production of reactive oxygen species and the body's ability to detoxify them, leading to cellular damage.
  • autophagy: A cellular process that degrades and recycles damaged organelles and proteins to maintain cellular health.

Simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free